FKBP10 and Bruck Syndrome: Phenotypic Heterogeneity or Call for Reclassification?

This publication has 9 references indexed in Scilit:

• Homozygosity mapping: One more tool in the clinical geneticist's toolbox
  Genetics in Medicine, 2010
• Mutations in the Gene Encoding the RER Protein FKBP65 Cause Autosomal-Recessive Osteogenesis Imperfecta
  The American Journal of Human Genetics, 2010
• FREM1 Mutations Cause Bifid Nose, Renal Agenesis, and Anorectal Malformations Syndrome
  The American Journal of Human Genetics, 2009
• Cyclic pamidronate treatment in Bruck syndrome: Proposal of a new modality of treatment
  Pediatrics International, 2008
• Mutation analysis ofCOL1A1andCOL1A2in patients diagnosed with osteogenesis imperfecta type I-IV
  Human Mutation, 2006
• Identification of PLOD2 as Telopeptide Lysyl Hydroxylase, an Important Enzyme in Fibrosis
  Journal of Biological Chemistry, 2003
• Developmental Regulation of FKBP65
  Molecular Biology of the Cell, 2000
• Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: Indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17
  Proceedings of the National Academy of Sciences, 1999
• Osteogenesis imperfecta with congenital joint contractures (Bruck Syndrome)
  Clinical Genetics, 1989